If you need more lookups,
subscriptions start at $34 USD/month.
Andreas Clemens Location
Basel, BS, CH
Andreas Clemens Work
2024 -now Global Head Secukinumab (Executive Medical Director Immunology), Global Medical Affairs @
2023 -2024 Global Head Medical Strategy, Autoinflammatory Disease and Inherited Retinal Dystrophies @
2021 -2023 Head New Medical Brand Incubator and Rare Disease, Europe @
2014 -2021 Executive Director, Medical Director Europe; Medical Head mult. Franchises Europe @
2013 -2016 PhD (Cardiology) @
2012 -2014 Senior Global Director Clin. Dev. and Medical Affairs CV and Metabloic, Global Head Pradaxa @
2010 -2012 Senior Director Clin. Dev. and Medical Affairs CV and Metabolism @
2005 -2010 Corporate Senior Director Medical Affairs CV and Metabolism @
now Medical Advisor (CV and Metabolism and Endocrine Care) @
now Internal Medicine, Diabetology, Gastroenterology @
now Internist, Endocrinologist, Diabetologist @
now Internal Medicine, Gastroenterology, Diabetology, Pathology @
now Internal Medicine, Endocrinology @
1986 -1987 Agricultural internship (focus on farm management and logistics, Trainee) @ Farm, Hans Clemens, Hackenstedt, Germany
Andreas Clemens Education
Johannes Gutenberg-Universität Mainz
Priv.-Doz. Dr. med. habil. (Internal Medicine (Cardiology))
2013-2016
Ruprecht-Karls-Universität Heidelberg
Endocrinologist, Diabetologist
1997-2001
Christian-Albrechts-Universität zu Kiel
Internist
1994-1997
Georg-August-Universität Göttingen 1987-1988
Andreas Clemens Summary
Andreas Clemens, based in Basel, BS, CH, is currently a Global Head Secukinumab (Executive Medical Director Immunology), Global Medical Affairs at Novartis. Andreas Clemens brings experience from previous roles at Novartis and Johannes Gutenberg-Universität Mainz. Andreas Clemens holds a 2013 - 2016 Priv.-Doz. Dr. med. habil. in Internal Medicine (Cardiology) @ Johannes Gutenberg-Universität Mainz. Andreas Clemens has 3 emails on RocketReach.
Looking for a different Andreas Clemens?
Find contact details for 700 million professionals.